New Jersey S696 mandates that hospital urine drug screenings include a test for fentanyl.

New Jersey S696 requires that general acute care hospitals include a test for fentanyl in their urine drug screenings. This is intended to assist in diagnosing patients and help prevent overdose deaths by ensuring that patients who have ingested fentanyl receive proper treatment. The bill defines "urine drug screening" as a chemical analysis for multiple drugs, including cocaine, opioids, and phencyclidine. The requirement will take effect immediately and expire on January 1, 2028.

New Jersey S696 mandates that hospital urine drug screenings include a test for fentanyl.

New Jersey S696 requires that general acute care hospitals include a test for fentanyl in their urine drug screenings. This is intended to assist in diagnosing patients and help prevent overdose deaths by ensuring that patients who have ingested fentanyl receive proper treatment. The bill defines "urine drug screening" as a chemical analysis for multiple drugs, including cocaine, opioids, and phencyclidine. The requirement will take effect immediately and expire on January 1, 2028.